Targeted Therapies in Lung Cancers: Current Landscape and Future Prospects.

Feng, Xin; Ding, Wenqing; Ma, Junhong; Liu, Baijun; Yuan, Hongmei

Feng, Xin; Ding, Wenqing; Ma, Junhong; Liu, Baijun; Yuan, Hongmei.

Affiliation

Feng X; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Ding W; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Ma J; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Liu B; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.
Yuan H; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China.

Recent Pat Anticancer Drug Discov ; 16(4): 540-551, 2021.

Article in En | MEDLINE | ID: mdl-34132185

Subject(s)

Drug Development/methods; Lung Neoplasms/drug therapy; Molecular Targeted Therapy; Antineoplastic Agents/pharmacology; Drug Development/trends; Drug Discovery/methods; Drug Discovery/trends; Humans; Lung Neoplasms/pathology; Patents as Topic; Signal Transduction/drug effects

Key words

Lung cancer; progress and prospects; science-technology-clinic; signal transduction; target prediction.; target-target interaction network; targeted therapies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Molecular Targeted Therapy / Drug Development / Lung Neoplasms Limits: Humans Language: En Journal: Recent Pat Anticancer Drug Discov Journal subject: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google